Danaher Corporation (0R2B.L)
USD 192.25
(3.1%)
USD 192.25
(3.1%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 14.12 Billion USD | -12.72% |
| 2022 | 16.18 Billion USD | -9.83% |
| 2021 | 17.95 Billion USD | 43.9% |
| 2020 | 12.47 Billion USD | 24.95% |
| 2019 | 9.98 Billion USD | 5.03% |
| 2018 | 9.5 Billion USD | -7.09% |
| 2017 | 10.23 Billion USD | 9.03% |
| 2016 | 9.38 Billion USD | 19.94% |
| 2015 | 7.82 Billion USD | 13.6% |
| 2014 | 6.88 Billion USD | -26.49% |
| 2013 | 9.36 Billion USD | -0.85% |
| 2012 | 9.44 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 3.42 Billion USD | -1.69% |
| 2024 Q1 | 3.48 Billion USD | -7.73% |
| 2024 Q3 | 3.4 Billion USD | -0.79% |
| 2023 Q4 | 3.77 Billion USD | -5.53% |
| 2023 FY | 14.03 Billion USD | -13.31% |
| 2023 Q1 | 4.37 Billion USD | -11.52% |
| 2023 Q2 | 4.04 Billion USD | -7.53% |
| 2023 Q3 | 4 Billion USD | -1.01% |
| 2022 FY | 16.18 Billion USD | -9.83% |
| 2022 Q4 | 4.93 Billion USD | 7.74% |
| 2022 Q3 | 4.58 Billion USD | -2.9% |
| 2022 Q2 | 4.72 Billion USD | 0.34% |
| 2022 Q1 | 4.7 Billion USD | -4.81% |
| 2021 Q1 | 4.28 Billion USD | 4.31% |
| 2021 Q2 | 4.39 Billion USD | 2.69% |
| 2021 Q3 | 4.35 Billion USD | -0.86% |
| 2021 Q4 | 4.94 Billion USD | 13.4% |
| 2021 FY | 17.95 Billion USD | 43.9% |
| 2020 Q3 | 3.44 Billion USD | 13.02% |
| 2020 Q4 | 4.1 Billion USD | 19.12% |
| 2020 FY | 12.47 Billion USD | 24.95% |
| 2020 Q1 | 2.44 Billion USD | -9.65% |
| 2020 Q2 | 3.04 Billion USD | 24.81% |
| 2019 FY | 9.98 Billion USD | 5.03% |
| 2019 Q4 | 2.7 Billion USD | 10.75% |
| 2019 Q3 | 2.44 Billion USD | -1.71% |
| 2019 Q2 | 2.48 Billion USD | 5.47% |
| 2019 Q1 | 2.35 Billion USD | 73.95% |
| 2018 FY | 9.5 Billion USD | -7.09% |
| 2018 Q2 | 2.81 Billion USD | 6.56% |
| 2018 Q4 | 1.35 Billion USD | -49.68% |
| 2018 Q3 | 2.69 Billion USD | -4.49% |
| 2018 Q1 | 2.64 Billion USD | -8.12% |
| 2017 Q2 | 2.48 Billion USD | 6.34% |
| 2017 Q1 | 2.33 Billion USD | -7.57% |
| 2017 FY | 10.23 Billion USD | 9.03% |
| 2017 Q4 | 2.87 Billion USD | 13.41% |
| 2017 Q3 | 2.53 Billion USD | 2.2% |
| 2016 Q2 | 2.38 Billion USD | 9.87% |
| 2016 Q1 | 2.16 Billion USD | -6.14% |
| 2016 Q3 | 2.28 Billion USD | -4.0% |
| 2016 FY | 9.38 Billion USD | 19.94% |
| 2016 Q4 | 2.52 Billion USD | 10.47% |
| 2015 FY | 7.82 Billion USD | 13.6% |
| 2015 Q4 | 2.3 Billion USD | 21.96% |
| 2015 Q3 | 1.89 Billion USD | 64.31% |
| 2015 Q2 | 1.15 Billion USD | -53.31% |
| 2015 Q1 | 2.46 Billion USD | -8.77% |
| 2014 FY | 6.88 Billion USD | -26.49% |
| 2014 Q4 | 2.7 Billion USD | 10.33% |
| 2014 Q1 | 2.45 Billion USD | -10.42% |
| 2014 Q3 | 2.45 Billion USD | 5.48% |
| 2014 Q2 | 2.32 Billion USD | -5.21% |
| 2013 Q3 | 2.42 Billion USD | -2.84% |
| 2013 Q2 | 2.49 Billion USD | 7.3% |
| 2013 FY | 9.36 Billion USD | -0.85% |
| 2013 Q1 | 2.32 Billion USD | -8.63% |
| 2013 Q4 | 2.73 Billion USD | 12.93% |
| 2012 Q4 | 2.54 Billion USD | 0.0% |
| 2012 FY | 9.44 Billion USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -6903.395% |
| Accuray Incorporated | 143.12 Million USD | -9772.066% |
| Align Technology, Inc. | 2.72 Billion USD | -419.417% |
| Elevance Health Inc. | 47.01 Billion USD | 69.945% |
| AxoGen, Inc. | 127.87 Million USD | -10949.158% |
| Boston Scientific Corporation | 9.84 Billion USD | -43.456% |
| CVS Health Corporation | 54.43 Billion USD | 74.042% |
| Cardinal Health, Inc. | 7.41 Billion USD | -90.572% |
| Centene Corporation | 153.99 Billion USD | 90.825% |
| DaVita Inc. | 3.82 Billion USD | -269.827% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 74.342% |
| Hologic, Inc. | 2.23 Billion USD | -531.379% |
| Humana Inc. | 106.44 Billion USD | 86.726% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -545.169% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | -319.894% |
| Masimo Corporation | 1 Billion USD | -1307.972% |
| McKesson Corporation | 12.58 Billion USD | -12.277% |
| Patterson Companies, Inc. | 1.38 Billion USD | -923.661% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | -377.17% |
| ResMed Inc. | 2.6 Billion USD | -441.594% |
| Henry Schein, Inc. | 3.65 Billion USD | -286.99% |
| Teladoc Health, Inc. | 1.84 Billion USD | -666.887% |
| Universal Health Services, Inc. | 1.17 Billion USD | -1102.078% |
| Veeva Systems Inc. | 1.68 Billion USD | -737.829% |
| Baxter International Inc. | 4.97 Billion USD | -184.0% |
| Becton, Dickinson and Company | 8.82 Billion USD | -60.138% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | -198.742% |
| Stryker Corporation | 13.05 Billion USD | -8.202% |
| Medtronic plc | 21.27 Billion USD | 33.582% |